Peter Greenleaf is president, CEO and a director of Aurinia, which develops and delivers therapeutics that address autoimmune disease. Previously, he served as CEO and a member of the board of directors of Cerecor Inc. and before that, as CEO and chair of Sucampo Pharmaceuticals Inc.